Glucose Dehydrogenase Mutant Specificity and Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current PQQ-dependent soluble glucose dehydrogenases have broad substrate specificity, which can impair the accuracy of blood glucose level determination, especially in patients with high levels of maltose, leading to reduced stability, activity, and affinity for glucose in mutant forms with improved specificity.

Innovation Solution

A mutant of PQQ-dependent soluble glucose dehydrogenase with a threonine substitution at position 348 to glycine, alanine, or serine, combined with mutations for improved stability and affinity, such as L110H, Q246H, G339T, and V436P, to enhance specificity for glucose over maltose.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If the substrate specificity of s-GDH is improved by mutation to reduce maltose interference, then measurement precision is improved, but enzyme stability and affinity for glucose deteriorate

Engineering Contradiction:
Improveglucose measurement accuracyVSAvoidenzyme stability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically varying multiple amino acid positions (348, 428, and other positions) to optimize the balance between substrate specificity and enzyme stability. Through site-directed mutagenesis, specific amino acid substitutions are introduced to enhance glucose specificity while maintaining adequate stability for diagnostic application.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite enzyme variants by combining multiple mutations across different amino acid positions. These composite mutant forms integrate changes at position 348 (T348G/T348S/T348A), position 428 (N428P), and other positions to achieve synergistic effects that simultaneously improve specificity and maintain stability.

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If the substrate specificity of s-GDH is improved by mutation to reduce maltose interference, then measurement precision is improved, but enzyme affinity for glucose deteriorates

Engineering Contradiction:
Improveglucose measurement accuracyVSAvoidenzyme affinity for glucose
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent applies parameter changes by systematically varying multiple amino acid positions (348, 428, and other positions) to optimize the balance between substrate specificity and enzyme stability. Through site-directed mutagenesis, specific amino acid substitutions are introduced to enhance glucose specificity while maintaining adequate stability for diagnostic application.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite enzyme variants by combining multiple mutations across different amino acid positions. These composite mutant forms integrate changes at position 348 (T348G/T348S/T348A), position 428 (N428P), and other positions to achieve synergistic effects that simultaneously improve specificity and maintain stability.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The mutant enzyme exhibits improved thermo stability, specific activity, and affinity for glucose, enabling more accurate glucose detection in biological samples with reduced interference from other sugars.

Implementation Method 1

PQQ-dependent glucose dehydrogenases (EC 1.1.5.2) catalyze a reaction in which glucose is oxidized to gluconolactone

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentEP3246402B1Improved mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase
Publication Date: 2020.05.20 ROCHE DIABETES CARE GMBH
  • EP3246402B1 patent drawingFigure 1
  • EP3246402B1 patent drawingFigure 2
  • EP3246402B1 patent drawingFigure 3a

AI summary

The present invention discloses a mutant of PQQ-dependent soluble glucose dehydrogenase (s-GDH; EC 1.1.5.2) with improved specificity for glucose as compared to maltose, having a substitution of threonine at position 348 by either glycine, alanine or serine, wherein said mutant additionally comprises, at least one mutation for improving the stability of the mutant and one or more mutation(s) for improving the affinity of the mutant to glucose, and/or one or more mutation(s) for further improving the specificity of the mutant for glucose as compared to maltose, and wherein position 348 correspond to the amino acid positions known from the A. calcoaceticus s-GDH wild-type sequence. Also disclosed are genes encoding such mutant s-GDH, and different applications of these s-GDH mutants, particularly for determining the concentration of glucose in a sample.